Navigating Peptide Process Development for Cell Therapy: From Mechanism of Action to Clinical Realization
Time: 1:10 pm
day: Conference Day Two
Details:
- Understanding the process of eliciting specific T cells through peptide-based cell therapy, outlining its framework and potential impact
- Bridging Preclinical Data to Clinical Trials: Bridge between the preclinical data to the clinical trials, showcasing key learnings that led to process optimization
- Unveiling the intricacies of manufacturing peptides for cell therapy, detailing the manufacturing process, release testing, and encountered challenges, offering valuable insights for navigating CMC hurdles
